
Stoke Therapeutics Appoints Clare Kahn, Ph.D., as Board Member
Stoke Therapeutics Strengthens Board with Appointment of Dr. Clare Kahn Stoke Therapeutics, Inc., a biotechnology company focused on transforming the treatment landscape for genetic diseases, has announced the appointment of Clare Kahn, Ph.D., to its Board of Directors. The addition…












